Hospira Recalls Injectable Meds; Possible Contamination by Glass Particles

Posted on Aug 06, 2012

On July 13, 2012, the Food and Drug Administration (FDA) recalled four different medications from producer Hospira Inc., the world’s leading provider of injectable drugs and infusion technologies, because of flaws in the glass vials that hold them. The vials had visible particles lodged in the neck of the vials, which could become dislodged and enter the medication, then be injected into the patient’s bloodstream. 

If the particles are injected into the patient, the patient could suffer bleeding, bruising, inflammation, rash, itching, chest pain and/or respiratory problems. So far, there have been no reports of illness related to this product. The recall was initiated in a timely manner. Anyone who has used any of the recalled medications and suffered any adverse symptoms is advised to contact the FDA or Hospira. 

Suppliers with existing stocks of the medications have been urged to stop distribution, quarantine the medications and arrange to have them returned. Safe, replacement drugs are being supplied, and the company does not expect a shortage to result from this recall. 

Receiving a medication should be a relief, a sign that your suffering will soon be eased. However, when mistakes are made during any part of the production or prescription process, those mistakes can take a toll on your health and your life. If you have suffered illness because of a prescription drug error, you should be able to gain compensation for your pain. Contact a Kentucky Medical Error Lawyer at Gray and White Law for a consultation about your prescription medication error claim. Call us today at 888-450-4456.

Matthew L. White
Connect with me
Founder & Partner of Louisville Personal Injury Law Firm Gray & White Law